Published Ahead-of-Print - Last Updated: July 17, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells

Kazemi, Alireza; Sadri, Mohammadreza; Houshmand, Mohammad; More

Anti-Cancer Drugs. ., Post Author Corrections: July 09, 2018

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Bernier, Cynthia; Soliman, Ahmed; Gravel, Michel; More

Anti-Cancer Drugs. ., Post Author Corrections: June 22, 2018


PDF Only


Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity

Philipp, Magdalena; Frischhut, Nina; Tschachler, Antonia; More

Anti-Cancer Drugs. ., Post Author Corrections: June 26, 2018

A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor

Mollica, Veronica; Di Nunno, Vincenzo; Corcioni, Beniamino; More

Anti-Cancer Drugs. ., Post Author Corrections: June 18, 2018


PDF Only


Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands

Franken, Margreet G.; Kanters, Tim A.; Coenen, Jules L.; More

Anti-Cancer Drugs. ., Post Author Corrections: May 25, 2018

Show: